Vivani Medical Advances Long-Acting Semaglutide Implant Toward Phase 2 Trial in 2027
Vivani Medical reports Phase 1 results for its NPM-139 implant, matching Wegovy weight loss without treatment-related side effects.
Last updated: 2026-11-14 16:58:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Vivani Medical, Inc. (VANI) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.01, with a market capitalization of $88.71M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.80 to $1.66. This page covers its latest market performance, valuation, price trends and company information.
$88.71M | |
$0.97 | |
$1.03 | |
$0.89 | |
$0.98 | |
359.33K | |
229.65K | |
-- | |
$1.66 | |
$0.80 | |
-- | |
-- |
Vivani Medical, Inc. (VANI) last closed at $1.01 as of 2026-11-14 00:58:00, up 3.21% ($0.03) from the previous close of $0.98.
During the latest regular trading session, VANI traded between $0.89 and $1.03, with a volume of 359.33K shares. The closing price was near the upper end and near the lower end of its 52-week range.
VANI is up 3.21% as of the last close.
Over the past seven days, Vivani Medical, Inc. (VANI) moved from $1.04 to $1.01, representing a decline of 2.88% ($0.03).
The stock traded between $0.80 and $1.16 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 405.99 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 24.4%
VANI is currently trading at $1.01, placing it 24.4% of the way from its 52-week low of $0.80 to its 52-week high of $1.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 36 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Vivani Medical, Inc. and VANI stock.
Vivani Medical reports Phase 1 results for its NPM-139 implant, matching Wegovy weight loss without treatment-related side effects.
Eligible investors can buy real shares of Vivani Medical, Inc. (VANI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to VANI, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between VANI shares and USD.
VANI Shares to USD
1.00 VANI shares = 1.01 USD
Calculations are estimates based on the latest available price and are for reference only.